Conference Coverage: ESMO 2023 – Focus on Bladder Cancer
Bladder cancer-specific discussions on therapeutic advances and their application in clinical decision-making
Faculty Chair
Daniel Petrylak, MD
Yale University, New Haven, CT, USA
FACULTY MEMBERS
Petros Grivas, MD, PhD
University of Washington, Seattle, WA, USA
Bradley McGregor, MD
Dana-Farber Cancer Institute, Boston, MA, USA
Joaquim Bellmunt, MD, PhD
Dana-Farber Cancer Institute, Boston, MA, USA
Begoña Pérez-Valderrama, MD
Hospital Universitario Virgen del Rocío, Sevilla, Spain
Andrea Necchi, MD
IRCCS San Raffaele Hospital and Scientific Institute, Milan, Italy
José Pablo Maroto-Rey, MD, PhD
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Yohann Loriot, MD, PhD
Gustave Roussy Cancer Campus Grand Paris, France
KEY TAKEAWAYS AND STRATEGIC INSIGHTS
- High-Risk BCG-Resistant Nonmuscle-Invasive Bladder Cancer (NMIBC)
- Muscle-Invasive Bladder Cancer (MIBC)
- Current Paradigms and Future Directions in Metastatic Bladder Cancer
- Maintenance Therapy in Metastatic Bladder Cancer
